Combined androgen blockade for advanced prostatic carcinoma

S. Goktas, A. Ziada, E. D. Crawford

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Hormonal therapy has been mainstay of treatment for advanced forms of prostate cancer for over 50 y. The choice of hormonal therapy for carcinoma of the prostate depends not only on the desired progression-free and overall survival but also on the patient's quality of life, treatment costs and treatment toxicities. At the present time, several important questions have been raised over optimal treatment modalities for advanced prostate cancer. The optimal form of this therapy is still an enigma.

Original languageEnglish (US)
Pages (from-to)172-179
Number of pages8
JournalProstate Cancer and Prostatic Diseases
Issue number4
StatePublished - Jul 1999

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology
  • Cancer Research


Dive into the research topics of 'Combined androgen blockade for advanced prostatic carcinoma'. Together they form a unique fingerprint.

Cite this